Literature DB >> 10983928

Laboratory diagnosis of atypical pneumonia.

M Hindiyeh1, K C Carroll.   

Abstract

"Atypical pneumonia" is a term loosely applied to lower respiratory tract infections that are not characterized by signs and symptoms of lobar consolidation. This description can apply to disease caused by a variety of bacterial, viral and even protozoan organisms. In reality, differentiation as to etiology of pneumonia cannot be distinguished on the basis of clinical presentation. This review will discuss the epidemiology, clinical manifestations, and laboratory diagnosis of Mycoplasma pneumoniae, Chlamydia sp., Legionella sp., Bordetella pertussis, and Coxiella bumetii, the most common agents associated with atypical pneumonia. Unfortunately, because many of these pathogens are intracellular, culture systems are either not available or the techniques employed are costly, time-consuming or unsafe. Until molecular techniques are standardized and widely available, diagnosis will depend upon serologic confirmation. Given the relative importance of these organisms as causes of community acquired pneumonia, current practice guidelines recommend empiric therapy with a macrolide in patients well enough to be treated as an outpatient. However, diagnostic tests should be performed in any patient requiring hospitalization.

Entities:  

Mesh:

Year:  2000        PMID: 10983928     DOI: 10.1053/srin.2000.9592

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  6 in total

Review 1.  Laboratory diagnosis of lower respiratory tract infections: controversy and conundrums.

Authors:  Karen C Carroll
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

2.  Community-acquired pneumonia in Shanghai, China: microbial etiology and implications for empirical therapy in a prospective study of 389 patients.

Authors:  H H Huang; Y Y Zhang; Q Y Xiu; X Zhou; S G Huang; Q Lu; D M Wang; F Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-06       Impact factor: 3.267

3.  Chlamydia pneumoniae and Mycoplasma pneumoniae pneumonia: comparison of clinical, epidemiological characteristics and laboratory profiles.

Authors:  I Puljiz; I Kuzman; O Dakovic-Rode; N Schönwald; B Mise
Journal:  Epidemiol Infect       Date:  2005-11-29       Impact factor: 2.451

4.  Outcomes of early administration of cidofovir in non-immunocompromised patients with severe adenovirus pneumonia.

Authors:  Se Jin Kim; Kang Kim; Sung Bum Park; Duck Jin Hong; Byung Woo Jhun
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

Review 5.  The atypical pneumonias: clinical diagnosis and importance.

Authors:  B A Cunha
Journal:  Clin Microbiol Infect       Date:  2006-05       Impact factor: 8.067

Review 6.  Laboratory diagnosis of community-acquired lower respiratory tract infection.

Authors:  M A Saubolle; P P McKellar
Journal:  Infect Dis Clin North Am       Date:  2001-12       Impact factor: 5.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.